Neurological Biomarker Market Top Players - Thermo Fisher Scientific Inc.; Abbott;Myriad RBM; Bio-Rad Laboratories, Inc.

According to our new research study on “Neurological Biomarker Market – COVID-19 Impact & Global Analysis and Forecast – by Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, and Others); Application (Alzheimer's Disease, Parkinson's Disease, Schizophrenia, Huntington's Disease, Spinal Muscular Atrophy, and Others); End User (Pharmaceutical and Biotechnology Companies, Clinical Diagnostics, Research Organizations); and Geography,” the global neurological biomarker market is expected to reach US$ 5,501.8 million by 2027 from US$ 14,454.7 million in 2019; it is estimated to grow at a CAGR of 13.0% during 2020–2027.The report highlights trends prevailing in the global neurological biomarkermarketwith the factors driving the market growth as well as those hampering it.
Request Sample Copy Of this Report @ http://bit.ly/2MgxITO

The genomic biomarkers segment held the largest share of the global neurological biomarker market, based on product, in 2019, and it is expected to register the highest CAGR during the forecast period. This segment is likely to witness a lucrative growth owing to increasing consumer awarenessabout the benefits of genetic medicines as well as technological advancements in the field of neurological biomarkers. In addition, the growing inclination toward gene counseling and genetic analysis for diagnostic purposes is also likely to propel the growth of the market for genomic biomarkers. The genetic biomarkers are significant modalities that directs towards a more personalized approach of predispositions and medical analysis.
The report analyzes Neurological Biomarker Market on By Product
• Proteomics Biomarker
• Genomics Biomarker
• Metabolomics Biomarker
• Imaging Biomarker
• Others

By Application
• Alzheimer's Disease
• Parkinson's Disease
• Schizophrenia
• Huntington's Disease
• Spinal Muscular Atrophy
• Others

By End User
• Pharmaceutical and Biotechnology Companies
• Clinical Diagnostics
• Research Organizations

Application-Based Insights
The global neurological biomarker market, based on application,is segmented into Alzheimer's disease, Parkinson's disease, schizophrenia, Huntington's disease, spinal muscular atrophy, and others. The Alzheimer's diseasesegment held the greatest share of the market in 2019. Moreover, it is also estimated to register the highest CAGR in the marketduring 2020–2027.
Purchase Copy of this Report @ https://bit.ly/2JqcUrO

End User-Based Insights
On the basis of enduser, the neurological biomarkermarket has been segmented into pharmaceutical and biotechnology companies, clinical diagnostics, and research organizations.In 2019, the pharmaceutical and biotechnology companiessegment held the largest share of the market, and it is further expected to register the highest CAGR during 2020–2027.

Contact:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

This release was published on openPR.